Cardio-Oncology highlighted at American Heart Association Annual Meeting 2017
There were several cardio-oncology sessions at the American Heart Association (AHA) annual meeting which occurred in November 2017 in Anaheim, California. A session called “The Emerging Science of Cardio-Oncology” focused on the rapidly evolving area of clinical practice in cancer patients with heart failure or acute coronary syndrome (ACS). Dr. Bonnie Ky (University of Pennsylvania) presented screening patterns and novel technologies to predict chemotherapy-induced cardiomyopathy. Dr. Daniel Addison (Ohio State) gave an overview of ACS in the cancer patient. Dr. Javid Moslehi (Vanderbilt) highlighted the complexities of care in the cardio-oncology population treated with new targeted therapies where a patient is no longer simply may have systolic cardiac dysfunction but is prone to myocarditis, arrhythmias, and other myocardial pathology. A session called “Cardio-Oncology: Two Killers Collide” included Drs. Greg Piazza (Brigham and Women’s Hospital), Jeff Weitz (McMaster), Ana Barac (Medstar) where novel issues related with vascular and thrombotic complications in cancer patients were discussed.